शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

LXCHEMNSELaxmi Organic Industries Limited· Chemicals & PetrochemicalsHighNeutral
Announced Mon, 28 Jul, 2025 · 21:55 IST

Laxmi Organic Industries Limited has informed the Exchange regarding Outcome of Board Meeting dated July 28, 2025 for approval of Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2025

Revenue declinedEBITDA margin compressionResults restatedResults View source PDFExplain this filing

LXCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.6%Reaction day
₹203.99
prior close
₹194.05
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.5%-5.1% vs market
Specialty Chemicals peers, median of 82sector+0.7%-4.4% vs sector

On the reaction day the stock moved 5.1 pts less than Nifty Microcap 250 and 4.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
-1.0
15m
+0.1
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.6+1.5-5.1+0.7-4.4
Next day
-2.9+1.8-4.7+1.0-3.9
2d
+0.2+1.1-0.9+0.1+0.1
3d
-4.2-0.5-3.7-1.1-3.1
4d
-5.9+0.0-5.9-0.4-5.5
5d
-6.4-0.3-6.0-1.0-5.3
1w
-9.1-1.7-7.4-2.9-6.2
15d
+6.4+0.1+6.3-2.3+8.8
1m
-0.8-2.9+2.1-5.4+4.6
2m
+1.5-3.0+4.4-6.6+8.1
3m
-0.5+1.0-1.5-6.5+6.0
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 82Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved Q1 FY26 (June 30, 2025) unaudited standalone and consolidated results. Standalone revenue from operations fell to ₹6,719.09 million from ₹7,184.45 million a year ago (down ~6.5% YoY), while profit after tax dropped to ₹229.70 million from ₹352.06 million (down ~34.7%). Consolidated revenue declined to ₹6,929.30 million and PAT fell to ₹213.91 million from ₹343.51 million. EPS stood at ₹0.83 (standalone) and ₹0.77 (consolidated). Two important items flatter the numbers: the company switched its depreciation method from Written Down Value to Straight Line Method (which alone lowered depreciation by ₹244.68 million – without it, standalone PBT would have been a loss of ₹67.15 million), and a revised income tax rate of 25.17% under Section 115BBA led to a one-time deferred tax reversal of ₹97.18 million. Comparatives were also restated following the amalgamation of wholly-owned subsidiary Yellowstone Fine Chemicals Private Limited, effective March 30, 2025. Deloitte Haskins & Sells LLP issued a clean limited-review report.

Likely market impact

Headline profits remain positive but underlying operating performance is weak – core earnings power has clearly compressed, and the reported PAT is propped up by an accounting change in depreciation and a tax-rate adjustment. The actual profit before tax (₹177.53 mn standalone) is a fraction of last year's ₹583.76 mn, so shareholders should look through the headline and focus on operating margins. The stock may see pressure given the steep YoY decline in profits and softer revenue, despite the optics of growth in PAT.

By the numbersConsolidated · Q1 FY26 vs Q1 FY25
Q1 FY26Q1 FY25Change
Revenue₹692.9 Cr₹718.2 Cr−3.5%
Operating profit₹8.68 Cr₹42.01 Cr−79.3%
Profit after tax₹21.39 Cr₹34.35 Cr−37.7%
EBITDA margin4.4%9.9%−5.5 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.